Abstract
Background
The presentation of eosinophilic esophagitis (EoE) is heterogeneous, but trends over time are not known.
Aim
To determine whether clinical and endoscopic phenotypes at EoE diagnosis have changed over the past 2 decades.
Methods
In this retrospective cohort study, adults and children with newly diagnosed EoE were phenotyped as follows: (1) inflammatory vs fibrostenotic vs mixed on endoscopy; (2) atopic vs non-atopic; (3) age at symptom onset; (4) age at diagnosis; (5) presence of autoimmune or connective tissue disease; and (6) responsive to steroids. The prevalence of different phenotypes was categorized by 5-year intervals. Multivariate analysis was performed to assess for changes in patient features over time.
Results
Of 1187 EoE patients, age at diagnosis increased over time (from 22.0 years in 2002–2006 to 31.8 years in 2017–2021; p < 0.001) as did the frequency of dysphagia (67% to 92%; p < 0.001). Endoscopic phenotypes were increasingly mixed (26% vs 68%; p < 0.001) and an increasing proportion of patients had later onset of EoE. However, there were no significant trends for concomitant autoimmune/connective tissue disease or steroid responder phenotypes. On multivariate analysis, after accounting for age, dysphagia, and food impaction, the increase in the mixed endoscopic phenotype persisted (aOR 1.51 per each 5-year interval, 95% CI 1.31–1.73).
Conclusion
EoE phenotypes have changed over the past two decades, with increasing age at diagnosis and age at symptom onset. The mixed endoscopic phenotype also increased, even after controlling for age and symptomatology. Whether this reflects changes in provider recognition or disease pathophysiology is yet to be elucidated.
Similar content being viewed by others
References
Furuta GT, Katzka DA. Eosinophilic esophagitis. N Engl J Med. 2015;373:1640–1648.
Dellon ES, Liacouras CA, Molina-Infante J et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155:1022–1033.
Ruffner MA, Cianferoni A. Phenotypes and endotypes in eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2020;124:233–239.
Chehade M, Jones SM, Pesek RD et al. Phenotypic characterization of eosinophilic esophagitis in a large multi-center patient population from the consortium for food allergy research. J Allergy Clin Immunol 2018;6:1534–1544.
Liacouras CA, Furuta GT, Hirano I et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3-20.e6.
Laserna-Mendieta EJ, Navarro P, Casabona-Francés S et al. Differences between childhood- and adulthood-onset eosinophilic esophagitis: an analysis from the EoE CONNECT registry. Dig Liver Dis. 2023;55:350–359.
Dellon ES, Kim HP, Sperry SLW et al. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointestinal Endosc. 2014;79:577-585.e4.
Lyles JL, Martin LJ, Shoda T et al. Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. J Allergy Clin Immunol. 2021;147:244-254.e6.
Shoda T, Wen T, Aceves SS et al. Eosinophilic esophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study by the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Lancet Gastroenterol Hepatol. 2018;3:477–488.
Greenberg SB, Ocampo AA, Xue Z et al. Increasing rates of esophageal stricture and dilation over two decades in eosinophilic esophagitis. Gastro Hep Adv. 2023;2:521–523.
Lipka S, Kumar A, Richter JE. Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter. J Clin Gastroenterol. 2016;50:134–140.
Hill DA, Grundmeier RW, Ramos M et al. Eosinophilic esophagitis is a late manifestation of the allergic. J Allergy Clin Immunol 2018;6:1528–1533.
Hill DA, Dudley JW, Spergel JM. The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy. J Allergy Clin Immunol. 2017;5:369–375.
Abonia JP, Wen T, Stucke EM et al. High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol. 2013;132:378–386.
Talathi S, Knight T, Dimmitt R et al. Concurrent eosinophilic esophagitis in pediatric patients with inflammatory bowel disease: a case series. Ann Allergy Asthma Immunol. 2019;123:313–316.
Reed CC, Corder SR, Kim E et al. Psychiatric comorbidities and psychiatric medication use are highly prevalent in patients with eosinophilic esophagitis and associate with clinical presentation. Am J Gastroenterol. 2020;115:853–858.
Dellon ES, Gibbs WB, Fritchie KJ et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305.
Noel RJ, Putnam PE, Collins MH et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568–575.
Munoz-Osores E, Maldonado-Campos I, Olivares-Labbe MT et al. Corticosteroids for eosinophilic esophagitis in children: a meta-analysis. Pediatrics 2020;146:e20200874.
Nhu QM, Aceves SS. Medical and dietary management of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2018;121:156–161.
Aceves SS, Newbury RO, Chen D et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65:109–116.
Kiran A, Dellon ES, Reed CC. Symptoms do not discriminate between elderly patients with and without eosinophilic esophagitis. Gastroenterology. In press, 2023. Sa1285.
Kiran A, Dellon ES, Reed CC. Older patients with esophageal symptoms are less likely to have diagnostic biopsies for eosinophilic esophagitis. Gastroenterology 2022;162:Su1195.
Ketchem CJ, Ocampo AA, Xue Z et al. Higher body mass index is associated with decreased treatment response to topical steroids in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2022;S1542–3565:01082–01085. https://doi.org/10.1016/j.cgh.2022.11.004.
Wolf WA, Cotton CC, Green DJ et al. Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients. Clin Gastroenterol Hepatol. 2015;13:452–458.
Eluri S, Selitsky SR, Perjar I et al. Clinical and molecular factors associated with histologic response to topical steroid treatment in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17:1081-1088.e2.
Dellon ES, Tsai YS, Coffey AR et al. Pre-treatment differential correlation of gene expression and response to topical steroids in eosinophilic esophagitis. Dis Esophagus 2023;36:71.
Jensen ET, Langefeld CD, Zimmerman KD et al. Epigenetic methylation in eosinophilic esophagitis: molecular ageing and novel biomarkers for treatment response. Clin Exp Allergy 2020;50:1372–1380.
Ketchem C, Thakkar KP, Reddy S et al. Older patients with eosinophilic esophagitis have high rates of treatment response to topical steroids. Dig Liver Dis. 2022;54:477–482.
Sperry SLW, Woosley JT, Shaheen NJ et al. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol. 2012;107:215–221.
Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.
Dellon ES, Gonsalves N, Hirano I et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–692.
Hirano I, Moy N, Heckman MG et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489–495.
Dellon ES, Cotton CC, Gebhart JH et al. Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clinical Gastroenterology and Hepatology. 2016;14:31–39.
Ma C, Bredenoord AJ, Dellon ES et al. Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis. Gastrointestinal Endoscopy. 2022;95:1126-1137.e2.
Redd WD, Ocampo AA, Xue Z et al. Eosinophilic esophagitis patients with multiple atopic conditions: clinical characteristics and treatment response to topical steroids. Ann Allergy Asthma Immunol. 2023;S1081–1206:00311–00313.
Xue Z, Miller TL, Abramson L et al. Association of eosinophilic esophagitis with autoimmune and connective tissue disorders, and the impact on treatment response. Dis Esophagus. 2022;36:43.
Wolf WA, Cotton CC, Green DJ et al. Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis. J Gastroenterol Hepatol Res. 2015;4:1780–1787.
Reed CC, Wolf WA, Cotton CC et al. Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: analysis of data from a prospective cohort study. Clin Gastroenterol Hepatol. 2018;16:226–233.
Dellon ES, Gupta SK. A conceptual approach to understanding treatment response in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17:2149–2160.
Schoepfer AM, Safroneeva E, Bussmann C et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145:1230-1236.e2.
Warners MJ, Oude Nijhuis RAB, De Wijkerslooth LRH et al. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113:836–844.
Chang NC, Thakkar KP, Ketchem CJ et al. A gap in care leads to progression of fibrosis in eosinophilic esophagitis patients. Clin Gastroenterol Hepatol. 2022;20:1701-1708.e2.
Hoofien A, Papadopoulou A, Gutiérrez-Junquera C et al. Sustained remission of eosinophilic esophagitis following discontinuation of dietary elimination in children. Clin Gastroenterol Hepatol. 2020;18:249-251.e1.
Collins CA, Palmquist J, Proudfoot JA et al. Evaluation of long-term course in children with eosinophilic esophagitis reveals distinct histologic patterns and clinical characteristics. J Allergy Clin Immunol. 2019;144:1050-1057.e5.
Rajan J, Newbury RO, Anilkumar A et al. Long term assessment of esophageal remodeling in pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol. 2016;137:147-156.e8.
Greuter T, Safroneeva E, Bussmann C et al. Maintenance treatment of eosinophilic esophagitis with swallowed topical steroids alters disease course over a 5-year follow-up period in adult patients. Clin Gastroenterol Hepatol. 2019;17:419-428.e6.
Lucendo AJ, Santander C, Savarino E et al. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe. Therapeutic Advances in Gastroenterology. 2022;15:1–16.
Navarro P, Laserna-Mendieta EJ, Guagnozzi D et al. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis. Dig Liver Dis. 2021;53:1479–1485.
Lipka S, Kumar A, Miladinovic B et al. Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2016;43:663–673.
Straumann A, Spichtin HP, Grize L et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669.
Funding
This study was supported by NIH T35 DK007386, T32 DK007634, and T32 HD094671.
Author information
Authors and Affiliations
Contributions
All authors approved the final manuscript: AK contributed to study design, data collection and interpretation, manuscript drafting, and critical revision. BAC, ZX, SL, AAO, JM, CJL, SAB, WDR, CCC, SE, and CCR contributed to data collection and interpretation and critical revision. ESD contributed to project conception, supervision, study design, data collection, data analysis/interpretation, manuscript drafting, and critical revision.
Corresponding author
Ethics declarations
Conflict of interest
None of the authors report any potential conflicts of interest with this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
An invited commentary on this article is available at https://doi.org/10.1007/s10620-023-08166-y.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kiran, A., Cameron, B.A., Xue, Z. et al. Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years. Dig Dis Sci 69, 521–527 (2024). https://doi.org/10.1007/s10620-023-08165-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-08165-z